FDA
Erythromycin Estolate
The FDA lists this product in 9 strengths and forms.
Composition
- Active ingredients
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE · CapsuleANDA062237-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE/5ML · SuspensionANDA062353-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE · CapsuleThis page
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE · CapsuleANDA062162-002 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 125MG BASE/5ML · SuspensionANDA062169-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE/5ML · SuspensionANDA062169-002 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE · CapsuleANDA062087-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE/5ML · SuspensionANDA062362-001 · Discontinued
- ERYTHROMYCIN ESTOLATE EQ 250MG BASE/5ML · SuspensionANDA062409-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062162.
At a glance
- Brand name
- Erythromycin Estolate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Barr
- Status
- Discontinued
- FDA approval
- 15 Jun 1981
- Application
- ANDA062162-001